1. Home
  2. RBBN vs REPL Comparison

RBBN vs REPL Comparison

Compare RBBN & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ribbon Communications Inc.

RBBN

Ribbon Communications Inc.

HOLD

Current Price

$2.89

Market Cap

671.1M

Sector

Technology

ML Signal

HOLD

Logo Replimune Group Inc.

REPL

Replimune Group Inc.

HOLD

Current Price

$9.88

Market Cap

721.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBBN
REPL
Founded
1997
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
671.1M
721.7M
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
RBBN
REPL
Price
$2.89
$9.88
Analyst Decision
Strong Buy
Buy
Analyst Count
4
9
Target Price
$6.00
$12.00
AVG Volume (30 Days)
700.0K
1.6M
Earning Date
10-22-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$868,592,000.00
N/A
Revenue This Year
$5.02
N/A
Revenue Next Year
$5.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.38
N/A
52 Week Low
$2.72
$2.68
52 Week High
$5.38
$14.80

Technical Indicators

Market Signals
Indicator
RBBN
REPL
Relative Strength Index (RSI) 43.66 55.27
Support Level $2.86 $9.50
Resistance Level $3.00 $10.29
Average True Range (ATR) 0.10 0.59
MACD 0.02 -0.14
Stochastic Oscillator 48.44 27.75

Price Performance

Historical Comparison
RBBN
REPL

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides network solutions to service providers and enterprises. The company enables service providers and enterprises to modernize their communications networks and provide secure real-time communications solutions to their customers and employees. The company has two separate lines of business; the Cloud and Edge segment, and the IP Optical Networks segment. The majority of the revenue for the company is generated from its Cloud and Edge segment that provides secure and reliable software and hardware products, solutions, and services for VoIP communications, Voice Over LTE among others to service providers and enterprise customers. The company generates majority of its revenue from United States.

About REPL Replimune Group Inc.

Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.

Share on Social Networks: